DDX6 regulates sequestered nuclear CUG-expanded DMPK-mRNA in dystrophia myotonica type 1

Nucleic Acids Research

Volumn 42, Issue 11, 2014, Pages 7186-7200

  Pettersson, Olof J ^a   Aagaard, Lars ^a   Andrejeva, Diana ^a   Thomsen, Rune ^a   Jensen, Thomas G ^a   Damgaard, Christian K ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DEAD BOX PROTEIN; MESSENGER RNA; MUSCLEBLIND LIKE PROTEIN 1; MYOTONIC DYSTROPHY PROTEIN KINASE; NUCLEAR PROTEIN; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DDX6 GENE; DMPK GENE; DYSTROPHIA MYOTONICA TYPE 1; FIBROBLAST; GENE; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MYOTONIC DYSTROPHY; PRIORITY JOURNAL; START CODON;

3' UNTRANSLATED REGIONS; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; DEAD-BOX RNA HELICASES; FIBROBLASTS; HUMANS; MYOTONIC DYSTROPHY; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, INSULIN; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84903122321     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku352     Document Type: Article

References (54)

1. Lee, J.E. and Cooper, T.A. (2009) Pathogenic mechanisms of myotonic dystrophy. Biochem.Soc. Trans., 37, 1281-1286.
2. Turner, C. and Hilton-Jones, D. (2010) The myotonic dystrophies: Diagnosis and management. J. Neurol. Neurosurg. Psychiatry, 81, 358-367.
3. Udd, B. and Krahe, R. (2012) The myotonic dystrophies: Molecular, clinical, and therapeutic challenges. Lancet Neurol., 11, 891-905.
4. Brook, J.D., McCurrach, M.E., Harley, H.G., Buckler, A.J., Church, D., Aburatani, H., Hunter, K., Stanton, V.P., Thirion, J.P., Hudson, T. et al. (1992) Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell, 68, 799-808.
5. Botta, A., Rinaldi, F., Catalli, C., Vergani, L., Bonifazi, E., Romeo, V., Loro, E., Viola, A., Angelini, C. and Novelli, G. (2008) The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients. J. Med. Genet., 45, 639-646.
6. Berul, C.I., Maguire, C.T., Aronovitz, M.J., Greenwood, J., Miller, C., Gehrmann, J., Housman, D., Mendelsohn, M.E. and Reddy, S. (1999) DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model. J. Clin. Invest., 103, R1-R7.
7. Jansen, G., Groenen, P.J., Bachner, D., Jap, P.H., Coerwinkel, M., Oerlemans, F., van den Broek, W., Gohlsch, B., Pette, D., Plomp, J.J. et al. (1996) Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat. Genet., 13, 316-324.
8. Reddy, S., Smith, D.B., Rich, M.M., Leferovich, J.M., Reilly, P., Davis, B.M., Tran, K., Rayburn, H., Bronson, R., Cros, D. et al. (1996) Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat. Genet., 13, 325-335.
9. Dansithong, W., Paul, S., Comai, L. and Reddy, S. (2005) MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J. Biol. Chem., 280, 5773-5780.
10. Du, H., Cline, M.S., Osborne, R.J., Tuttle, D.L., Clark, T.A., Donohue, J.P., Hall, M.P., Shiue, L., Swanson, M.S., Thornton, C.A. et al. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol., 17, 187-193.
11. Ladd, A.N., Charlet, N. and Cooper, T.A. (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol., 21, 1285-1296.
12. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S. and Thornton, C.A. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 15, 2087-2097.
13. Paul, S., Dansithong, W., Jog, S.P., Holt, I., Mittal, S., Brook, J.D., Morris, G.E., Comai, L. and Reddy, S. (2011) Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex. J. Biol. Chem., 286, 38427-38438.
14. Philips, A.V., Timchenko, L.T. and Cooper, T.A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-741.
15. Savkur, R.S., Philips, A.V. and Cooper, T.A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet., 29, 40-47.
16. Wang, E.T., Cody, N.A., Jog, S., Biancolella, M., Wang, T.T., Treacy, D.J., Luo, S., Schroth, G.P., Housman, D.E., Reddy, S. et al. (2012) Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell, 150, 710-724.
17. Jones, K., Jin, B., Iakova, P., Huichalaf, C., Sarkar, P., Schneider-Gold, C., Schoser, B., Meola, G., Shyu, A.B., Timchenko, N. et al. (2011) RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. Am. J. Pathol., 179, 2475-2489.
18. Kuyumcu-Martinez, N.M., Wang, G.S. and Cooper, T.A. (2007) Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol. Cell, 28, 68-78.
19. Mahadevan, M.S., Yadava, R.S., Yu, Q., Balijepalli, S., Frenzel-McCardell, C.D., Bourne, T.D. and Phillips, L.H. (2006) Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat. Genet., 38, 1066-1070.
20. Ward, A.J., Rimer, M., Killian, J.M., Dowling, J.J. and Cooper, T.A. (2010) CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1. Hum. Mol. Genet., 19, 3614-3622.
21. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. and Housman, D.E. (1997) Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. U.S.A., 94, 7388-7393.
22. Fardaei, M., Larkin, K., Brook, J.D. and Hamshere, M.G. (2001) In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res., 29, 2766-2771.
23. Fardaei, M., Rogers, M.T., Thorpe, H.M., Larkin, K., Hamshere, M.G., Harper, P.S. and Brook, J.D. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet., 11, 805-814.
24. Taneja, K.L. (1998) Localization of trinucleotide repeat sequences in myotonic dystrophy cells using a single fluorochrome-labeled PNA probe. Biotechniques, 24, 472-476.
25. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D. and Singer, R.H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol., 128, 995-1002.
26. Dansithong, W., Wolf, C.M., Sarkar, P., Paul, S., Chiang, A., Holt, I., Morris, G.E., Branco, D., Sherwood, M.C., Comai, L. et al. (2008) Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. PloS One, 3, e3968.
27. Laurent, F.X., Sureau, A., Klein, A.F., Trouslard, F., Gasnier, E., Furling, D. and Marie, J. (2012) New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats. Nucleic acids research, 40, 3159-3171.
28. Ravel-Chapuis, A., Belanger, G., Yadava, R.S., Mahadevan, M.S., DesGroseillers, L., Cote, J. and Jasmin, B.J. (2012) The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing. J. Cell Biol., 196, 699-712.
29. Russell, R., Jarmoskaite, I. and Lambowitz, A.M. (2013) Toward a molecular understanding of RNA remodeling by DEAD-box proteins. RNA Biol., 10, 44-55.
30. Weston, A. and Sommerville, J. (2006) Xp54 and related (DDX6-like) RNA helicases: Roles in messenger RNP assembly, translation regulation and RNA degradation. Nucleic Acids Res., 34, 3082-3094.
31. Franks, T.M. and Lykke-Andersen, J. (2008) The control of mRNA decapping and P-body formation. Mol. Cell, 32, 605-615.
32. Minshall, N., Kress, M., Weil, D. and Standart, N. (2009) Role of p54 RNA helicase activity and its C-terminal domain in translational repression, P-body localization and assembly. Mol. Biol. Cell, 20, 2464-2472.
33. Chu, C.Y. and Rana, T.M. (2006) Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol., 4, e210.
34. Fenger-Gron, M., Fillman, C., Norrild, B. and Lykke-Andersen, J. (2005) Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell, 20, 905-915.
35. Kedersha, N. and Anderson, P. (2009) Regulation of translation by stress granules and processing bodies. Prog. Mol. Biol. Transl. Sci., 90, 155-185.
36. Raoul, C., Abbas-Terki, T., Bensadoun, J.C., Guillot, S., Haase, G., Szulc, J., Henderson, C.E. and Aebischer, P. (2005) Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat. Med., 11, 423-428.
37. Damgaard, C.K. and Lykke-Andersen, J. (2011) Translational coregulation of 5'TOP mRNAs by TIA-1 and TIAR. Genes Dev., 25, 2057-2068.
38. Margolis, J.M., Schoser, B.G., Moseley, M.L., Day, J.W. and Ranum, L.P. (2006) DM2 intronic expansions: Evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression. Hum. Mol. Genet., 15, 1808-1815.
39. Damgaard, C.K., Lykke-Andersen, S. and Kjems, J. (2012) Stable Cell Lines with Splicing Reporters, in Alternative pre-mRNA Splicing: Theory and Protocols (eds Stamm, S., Smith, C. W. J. and L̈uhrmann, R.), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 408-414.
40. Ivanov, P., Kedersha, N. and Anderson, P. (2011) Stress puts TIA on TOP. Genes Dev., 25, 2119-2124.
41. Damgaard, C.K., Tange, T.O. and Kjems, J. (2002) hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure. RNA, 8, 1401-1415.
42. Amack, J.D. and Mahadevan, M.S. (2001) The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum. Mol. Genet., 10, 1879-1887.
43. Dansithong, W., Jog, S.P., Paul, S., Mohammadzadeh, R., Tring, S., Kwok, Y., Fry, R.C., Marjoram, P., Comai, L. and Reddy, S. (2011) RNA steady-state defects in myotonic dystrophy are linked to nuclear exclusion of SHARP. EMBO Rep., 12, 735-742.
44. Franks, T.M. and Lykke-Andersen, J. (2007) TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements. Genes Dev., 21, 719-735.
45. Andrei, M.A., Ingelfinger, D., Heintzmann, R., Achsel, T., Rivera-Pomar, R. and Luhrmann, R. (2005) A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA, 11, 717-727.
46. Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W. and Ranum, L.P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 293, 864-867.
47. Larsen, J., Pettersson, O.J., Jakobsen, M., Thomsen, R., Pedersen, C.B., Hertz, J.M., Gregersen, N., Corydon, T.J. and Jensen, T.G. (2011) Myoblasts generated by lentiviral mediated MyoD transduction of myotonic dystrophy type 1 (DM1) fibroblasts can be used for assays of therapeutic molecules. BMC Res. Notes, 4, 490-498.
48. Dutta, A., Zheng, S., Jain, D., Cameron, C.E. and Reese, J.C. (2011) Intermolecular interactions within the abundant DEAD-box protein Dhh1 regulate its activity in vivo. J. Biol. Chem., 286, 27454-27470.
49. Mallam, A.L., Del Campo, M., Gilman, B., Sidote, D.J. and Lambowitz, A.M. (2012) Structural basis for RNA-duplex recognition and unwinding by the DEAD-box helicase Mss116p. Nature, 490, 121-125.
50. Coller, J. and Parker, R. (2005) General translational repression by activators of mRNA decapping. Cell, 122, 875-886.
51. Coller, J.M., Tucker, M., Sheth, U., Valencia-Sanchez, M.A. and Parker, R. (2001) The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA, 7, 1717-1727.
52. Smillie, D.A. and Sommerville, J. (2002) RNA helicase p54 (DDX6) is a shuttling protein involved in nuclear assembly of stored mRNP particles. J. Cell Sci., 115, 395-407.
53. Holt, I., Mittal, S., Furling, D., Butler-Browne, G.S., Brook, J.D. and Morris, G.E. (2007) Defective mRNA in myotonic dystrophy accumulates at the periphery of nuclear splicing speckles. Genes Cell, 12, 1035-1048.
54. Minshall, N., Thom, G. and Standart, N. (2001) A conserved role of a DEAD box helicase in mRNA masking. RNA, 7, 1728-1742